Prevalence and risk factors of cytomegalovirus reactivation in critically Ill patients with COVID-19 pneumonia.

Tanapat Tassaneeyasin Somnuek SungkanuparphSirawat SrichatrapimukAttawit CharoensriKanin ThammavaranucuptKulapong JayanamaSuppachok Kirdlarp

Published in: PloS one (2024)

In critically ill COVID-19 patients, CMV reactivation is frequent and a high cumulative corticosteroids dose is a significant risk factor for CMV reactivation, which is associated with poor outcomes. Further prospective studies are warranted to determine optimal management.

Keyphrases

sars cov
epstein barr virus
type diabetes
skeletal muscle
intensive care unit
case control
respiratory failure